Q2 2026 saw a 9% year-over-year sales decline to $4.5 million, with a net loss of $0.4 million and an Adjusted EBITDA loss of $0.2 million. Despite macroeconomic headwinds, the company maintained a strong cash position and continued commercial trials with global producers.Original document: EcoSynt…
Q2 2026 saw a 9% year-over-year sales decline to $4.5 million, with a net loss of $0.4 million and an Adjusted EBITDA loss of $0.2 million. Despite macroeconomic headwinds, the company maintained a strong cash position and continued commercial trials with global producers.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
